Results 291 to 299 of about 53,650 (299)

Effect of iron salts, haemosiderins, and chelating agents on the lymphocytes of a thalassaemia patient without chelation therapy as measured in the comet assay

Teratogenesis, Carcinogenesis, and Mutagenesis, 2000
Diana Anderson, Cristofol Vives-Bauza, W Chua-Anusorn   +2 more
exaly  

Iron-chelating agents attenuate NMDA-Induced neuronal injury via reduction of oxidative stress in the rat retina

Experimental Eye Research, 2018
Kenji Sakamoto, Tasuku Hirayama, Asami Mori   +2 more
exaly  

New insights into the role of organic chelating agents in Fe(II) activated persulfate processes

Chemical Engineering Journal, 2015
Jinquan Wan, Zeyu Guan
exaly  

Existing Tubular Injury in β-Thalassemia Major Patients Receiving Iron Chelating Agents with Normal Creatinine Level in East Java, Indonesia

Hemoglobin
Pradana Zaky Romadhon, Ami Ashariati, Siprianus Ugroseno Yudho Bintoro   +2 more
exaly  

Clinical usefulness of iron chelating agents.

Progress in hematology, 1969
H S, Waxman, E B, Brown
openaire   +1 more source

Chelating Agents in the Diagnosis and Treatment of Iron Overload in Thalassemia

Annals of the New York Academy of Sciences, 1964
openaire   +2 more sources

Salvage Structures, Known as Iron Chelating Agents, Acquired from the Nature and Matured in the Labs

Current Medicinal Chemistry
exaly  

Chelators as Medicinal Agents: Iron and Beyond

2008
openaire   +1 more source

Iron chelating agents in clinical practice

2007
ARENA, Giuseppe, CRISPONI G, REMELLI M.
openaire   +2 more sources